Related Experiment Video
Updated: Aug 9, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Complications associated with the bacille Calmette-Guérin vaccination in Ireland
T Bolger1, M O'Connell, A Menon
1Our Lady's Hospital for Sick Children, Dublin, Eire. turloughbolger@yahoo.co.uk
Insights
A new Bacillus Calmette-Guérin (BCG) vaccine strain in Ireland led to a rise in localized complications, including abscesses and adenitis, in infants. This suggests a need to re-evaluate its suitability for national immunization programs.
Area of Science:
- Pediatric Infectious Diseases
- Vaccine Safety Surveillance
- Immunology
Background:
- BCG vaccination is standard for Irish newborns.
- A new BCG vaccine strain was introduced in Ireland.
- An increase in localized post-vaccination complications was observed.
Observation:
- A population surveillance study analyzed complications from August 2002 to July 2004.
- Infants with inoculation site abscesses or adenopathy were included.
- Data were gathered via infectious disease records and laboratory reports.
Findings:
- Fifty-eight infants presented with complications, primarily suppurative adenitis or inoculation site abscesses.
- The complication rate was estimated at 1 in 931 vaccinees.
- Twenty-six infants required surgical intervention.
Implications:
- Hospitals play a key role in sentinel surveillance for adverse events.
- A responsive adverse event reporting system is crucial.
- The suitability of this BCG strain for national immunization warrants serious consideration given the observed complications.
Introduction:
BCG vaccination is currently recommended for all newborns in Ireland except where specifically contraindicated. This paper describes a marked increase in the number of referrals of patients with localised complications after vaccination to two Dublin paediatric hospitals. This increase coincided with the introduction of a new strain of BCG vaccine
Methods:
A population surveillance study was undertaken to determine the frequency and spectrum of complications associated with the new strain of BCG vaccine introduced in Ireland. Patients were identified though review of the infectious disease service case records and microbiology laboratory culture reports for the two year period from August 2002 to July 2004. Prospectively gathered data were supplemented by retrospective chart review. All infants who had inoculation site abscesses, suppurative adenopathy, or non-suppurative adenopathy with nodes > or =2 cm were included.
Results:
Fifty eight patients presented a median of 13 weeks post-inoculation: 32 with suppurative adenitis, 17 with inoculation site abscess, three with both inoculation site abscess and suppurative adenitis, and six with non-suppurative adenopathy. The overall complication rate was estimated at 1/931 vaccinees with 1/1543 developing suppurative adenitis. Twenty six infants required surgery.
Discussion:
This series illustrates the role of hospitals in sentinel surveillance and highlights the importance of having a well functioning and responsive system of adverse event reporting. These events raise a serious question as to the suitability of this vaccine strain for use in a national immunisation programme in a country where the prevalence of tuberculous disease is 10.4/100,000.
More Related Videos
Related Concept Videos
Vaccinations
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Hypersensitivity Reactions: Immune-Complex Reactions
Diphtheria
Smallpox
Bacterial Meningitis I: Introduction

